Genrex Plus Syrup is a combination expectorant and bronchodilator formulation containing Ambroxol (15 mg), Guaifenesin (50 mg), Menthol (1.5 mg), and Terbutaline (1.25 mg) per dose. Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of thick mucus from the respiratory tract, thereby improving airway patency. Guaifenesin serves as an expectorant, promoting the loosening and expulsion of mucus, which aids in alleviating productive cough. Menthol provides a mild local anesthetic effect and imparts a soothing sensation to the throat, contributing to symptomatic relief. Terbutaline is a selective β2-adrenergic receptor agonist that induces bronchodilation by relaxing the smooth muscles of the airways, thus enhancing airflow and reducing bronchospasm. This synergistic combination is indicated for the management of respiratory conditions characterized by excessive mucus production and bronchoconstriction, such as bronchitis, chronic obstructive pulmonary disease (COPD), and asthma exacerbations. Genrex Plus Syrup should be used under medical supervision, with caution advised in patients with cardiovascular disorders, hypertension, or hypersensitivity to any component. Dosage and duration of therapy must be tailored according to clinical response and patient tolerance to optimize therapeutic outcomes while minimizing adverse effects.